Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Bruce James Brew

Showing results (1-10 of 21) with videos related to

Pageof 3
Sort By:
Neurology|September 26, 2007
Lost in translation: again, another failed neuroprotection trialBruce James Brew
The Lancet. Neurology|December 13, 2025
Neuroinfectious diseases in 2025: pathogens old and newBruce James Brew
AIDS (London, England)|August 28, 2007
HAD and the need for new trial design methodologyBruce James Brew
Handbook of Clinical Neurology|April 2, 2018
Introduction to HIV infection and HIV neurologyBruce James Brew
AIDS Research and Therapy|October 9, 2021
MR spectroscopy in HIV associated neurocognitive disorder in the era of cART: a reviewJoga Chaganti, Bruce James Brew
Handbook of Clinical Neurology|April 2, 2018
Progressive multifocal leukoencephalopathyShaun Zhai, Bruce James Brew
AIDS (London, England)|January 28, 2021
HIV neurocognitive impairment and Alzheimer's disease: sniffing out the differenceDavid E Vance, Bruce James Brew
AIDS (London, England)|May 1, 2024
Plasma neurofilament light chain protein predicts greater brain-age gap, cognition, and cardiovascular risk in people with HIVDavid E Vance, Bruce James Brew
Handbook of Clinical Neurology|April 2, 2018
Neurologic sequelae of primary HIV infectionBruce James Brew, Justin Y Garber
Handbook of Clinical Neurology|April 2, 2018
HIV-associated neurocognitive disorderRuaridh Cameron Smail, Bruce James Brew
Pageof 3

Showing results (1-10 of 21) with videos related to

Sort By:
Pageof 3
Neurology|September 26, 2007
Lost in translation: again, another failed neuroprotection trialBruce James Brew
The Lancet. Neurology|December 13, 2025
Neuroinfectious diseases in 2025: pathogens old and newBruce James Brew
AIDS (London, England)|August 28, 2007
HAD and the need for new trial design methodologyBruce James Brew
Handbook of Clinical Neurology|April 2, 2018
Introduction to HIV infection and HIV neurologyBruce James Brew
AIDS Research and Therapy|October 9, 2021
MR spectroscopy in HIV associated neurocognitive disorder in the era of cART: a reviewJoga Chaganti, Bruce James Brew
Handbook of Clinical Neurology|April 2, 2018
Progressive multifocal leukoencephalopathyShaun Zhai, Bruce James Brew
AIDS (London, England)|January 28, 2021
HIV neurocognitive impairment and Alzheimer's disease: sniffing out the differenceDavid E Vance, Bruce James Brew
AIDS (London, England)|May 1, 2024
Plasma neurofilament light chain protein predicts greater brain-age gap, cognition, and cardiovascular risk in people with HIVDavid E Vance, Bruce James Brew
Handbook of Clinical Neurology|April 2, 2018
Neurologic sequelae of primary HIV infectionBruce James Brew, Justin Y Garber
Handbook of Clinical Neurology|April 2, 2018
HIV-associated neurocognitive disorderRuaridh Cameron Smail, Bruce James Brew
Pageof 3